Author: Nishanth Kandepedu
Deep insights into modern small-molecule drug discovery and development
Small-molecule therapeutics move through one of the most complex and data-intensive pipelines in biomedical R&D. From early target validation and hit discovery to SAR-driven lead optimization, ADMET refinement, and translational development, each stage demands precise, high-quality, context-rich data.
This whitepaper breaks down the scientific principles, decision points, and optimization challenges that shape the end-to-end small-molecule journey. It also explains how curated knowledge bases like GOSTAR™ accelerate discovery through reliable SAR, ADMET, and bioactivity intelligence—reducing uncertainty and enabling more informed go/no-go decisions.
Download the whitepaper to explore:
- The full lifecycle of small-molecule drug development
- Key scientific and computational frameworks guiding target selection, hit identification, and lead optimization
- How SAR, ADMET, and assay data shape candidate quality
- The impact of curated datasets in speeding the “data-to-decision” pathway
Access the complete technical guide — fill the form to download.
Download Whitepaper
Please fill out the form and we’ll mail you whitepaper direct to your inbox.
"*" indicates required fields
